Makindo Medical Notes"One small step for man, one large step for Makindo" |
![]() |
---|---|
Download all this content in the Apps now Android App and Apple iPhone/Pad App | |
MEDICAL DISCLAIMER: The contents are under continuing development and improvements and despite all efforts may contain errors of omission or fact. This is not to be used for the assessment, diagnosis, or management of patients. It should not be regarded as medical advice by healthcare workers or laypeople. It is for educational purposes only. Please adhere to your local protocols. Use the BNF for drug information. If you are unwell please seek urgent healthcare advice. If you do not accept this then please do not use the website. Makindo Ltd. |
The CDC childhood vaccination schedule is carefully designed to protect children π§πΆ from potentially life-threatening infectious diseases π¦ . Following the timeline ensures early immunity, school readiness, and herd protection.
β
HepB at birth prevents vertical transmission.
β
Rotavirus is oral β do not give after 8 months of age due to intussusception risk.
β
HPV vaccine protects both boys and girls (genital & oropharyngeal cancers).
β
MenACWY booster is critical at 16, as meningitis risk peaks in adolescents.
β
Annual flu vaccine is recommended for all children β₯6 months.
Age | UK π¬π§ (NHS) | US πΊπΈ (CDC) | Why Different? π€ |
---|---|---|---|
At Birth πΆ | BCG only for babies at high TB risk π | HepB (universal, 1st dose) | π¬π§ low TB incidence β targeted BCG. πΊπΈ higher perinatal HepB carriage risk β universal HepB. |
8 weeks / 2 months | 6-in-1 (DTaP, Polio, Hib, HepB)
PCV, Rotavirus, MenB | DTaP, Hib, IPV (Polio), PCV13,
Rotavirus | π¬π§ added MenB after high incidence of infant meningitis B. πΊπΈ does not routinely use infant MenB. |
12 weeks / 2 months | 6-in-1 (2nd), Rotavirus | Same as 2 mo (DTaP, Hib, IPV, PCV, RV) | Schedules aligned, only minor timing differences. |
16 weeks / 4 months | 6-in-1 (3rd), PCV, MenB | DTaP, Hib, IPV, PCV13, Rotavirus | π¬π§ boosts MenB again to cover peak infant risk. πΊπΈ no infant MenB. |
6 months | β | HepB (3rd dose, 6β18 mo), Influenza (annual from 6 mo) βοΈ | πΊπΈ more universal HepB policy. π¬π§ Flu starts later (2 yrs) via nasal spray programme. |
1 year | MMR (1st), Hib/MenC, PCV (3rd), MenB (3rd) | Hib, MMR (1st), PCV, Varicella π, HepA | πΊπΈ gives Varicella & HepA universally β higher burden & policy for elimination. π¬π§ avoids Varicella universal β risk of shifting infection to adults (more severe). |
2β3 years | Annual Flu vaccine π¨ (nasal spray) | Annual Flu from 6 mo βοΈ | π¬π§ targets preschool spreaders (nasal spray easier). πΊπΈ universal flu β high winter mortality in young children. |
3β4 years / 4β6 years | MMR (2nd), 4-in-1 booster (DTaP, Polio) | DTaP, IPV, MMR, Varicella (boosters) | Similar rationale β maintain long-term herd immunity before school entry. |
12β13 years | HPV (2 doses, school-based) | HPV (2 doses, start 11β12 yrs) | Very similar. π¬π§ school-based catch-up ensures equity; πΊπΈ relies on family physician visits. |
14 years / 16 years | 3-in-1 booster (Tetanus, Diphtheria, Polio)
MenACWY | Tdap booster (11β12 yrs)
MenACWY booster at 16 | Both give teenage protection. πΊπΈ booster of MenACWY later (college dorm outbreaks risk). π¬π§ booster earlier at 14. |
The US childhood vaccination schedule is evidence-based and saves lives every year. It protects against diseases like measles, meningitis, hepatitis, and polio, many of which once caused high childhood mortality. π‘ Timely vaccination maximises protection, reduces school outbreaks, and ensures lifelong immunity.